Header Logo

Connection

Stephen Eeden to Male

Back to Details
This is a "connection" page, showing publications Stephen Eeden has written about Male.
Stephen Eeden
Connection Strength
2.664
Male
  1. A Large-Scale Association Study Detects Novel Rare Variants, Risk Genes, Functional Elements, and Polygenic Architecture of Prostate Cancer Susceptibility. Cancer Res. 2021 04 01; 81(7):1695-1703.
    View in: PubMed
    Score: 0.071
  2. Association of imputed prostate cancer transcriptome with disease risk reveals novel mechanisms. Nat Commun. 2019 07 15; 10(1):3107.
    View in: PubMed
    Score: 0.065
  3. Evaluating the Use of Electronic Health Records for Type 2 Diabetes Surveillance in 2 California Counties, 2010-2014. Public Health Rep. 2017 Jul/Aug; 132(4):463-470.
    View in: PubMed
    Score: 0.056
  4. Development of a Clinical Prediction Model for Diabetes in Chronic Pancreatitis: The PREDICT3c Study. Diabetes Care. 2023 Jan 01; 46(1):46-55.
    View in: PubMed
    Score: 0.041
  5. What epidemiological studies are telling us about lower urinary tract symptoms that should change practice. J Urol. 2012 Aug; 188(2):353-4.
    View in: PubMed
    Score: 0.040
  6. The Kaiser Permanente Research Bank Cancer Cohort: a collaborative resource to improve cancer care and survivorship. BMC Cancer. 2022 Feb 25; 22(1):209.
    View in: PubMed
    Score: 0.039
  7. Multicenter Comparison of 17-Gene Genomic Prostate Score as a Predictor of Outcomes in African American and Caucasian American Men with Clinically Localized Prostate Cancer. J Urol. 2021 Apr; 205(4):1047-1054.
    View in: PubMed
    Score: 0.036
  8. Long-term follow-up of a racially and ethnically diverse population of men with localized prostate cancer who did not undergo initial active treatment. Cancer Med. 2020 11; 9(22):8530-8539.
    View in: PubMed
    Score: 0.035
  9. Cervical dystonia incidence and diagnostic delay in a multiethnic population. Mov Disord. 2020 03; 35(3):450-456.
    View in: PubMed
    Score: 0.033
  10. Selecting Active Surveillance: Decision Making Factors for Men with a Low-Risk Prostate Cancer. Med Decis Making. 2019 11; 39(8):962-974.
    View in: PubMed
    Score: 0.033
  11. Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Diabetes Care. 2010 Jan; 33(1):55-60.
    View in: PubMed
    Score: 0.033
  12. Statins as a free pass: Body mass index and other cardiovascular risk factors among lipid-lowering medication users and nonusers in the California Men's Health Study. Prev Med. 2019 12; 129:105822.
    View in: PubMed
    Score: 0.033
  13. A genome-wide association study of prostate cancer in Latinos. Int J Cancer. 2020 04 01; 146(7):1819-1826.
    View in: PubMed
    Score: 0.032
  14. Reply to Liu et al.: Tissue specificity of SIM1 gene expression and erectile dysfunction. Proc Natl Acad Sci U S A. 2019 02 26; 116(9):3349-3350.
    View in: PubMed
    Score: 0.031
  15. Genetic variation in the SIM1 locus is associated with erectile dysfunction. Proc Natl Acad Sci U S A. 2018 10 23; 115(43):11018-11023.
    View in: PubMed
    Score: 0.031
  16. The Use of 5-Alpha Reductase Inhibitors to Manage Benign Prostatic Hyperplasia and the Risk of All-cause Mortality. Urology. 2018 Sep; 119:70-78.
    View in: PubMed
    Score: 0.030
  17. High-resolution mapping of traffic related air pollution with Google street view cars and incidence of cardiovascular events within neighborhoods in Oakland, CA. Environ Health. 2018 05 15; 17(1):38.
    View in: PubMed
    Score: 0.030
  18. LSD1 activates a lethal prostate cancer gene network independently of its demethylase function. Proc Natl Acad Sci U S A. 2018 05 01; 115(18):E4179-E4188.
    View in: PubMed
    Score: 0.030
  19. Quality of life among men with low-risk prostate cancer during the first year following diagnosis: the PREPARE prospective cohort study. Transl Behav Med. 2018 03 01; 8(2):156-165.
    View in: PubMed
    Score: 0.029
  20. The Relationship Between Nonsteroidal Anti-inflammatory Drug Use and Age-related Macular Degeneration. Am J Ophthalmol. 2018 04; 188:111-122.
    View in: PubMed
    Score: 0.029
  21. Identification of fluorescence in situ hybridization assay markers for prediction of disease progression in prostate cancer patients on active surveillance. BMC Cancer. 2018 01 02; 18(1):2.
    View in: PubMed
    Score: 0.029
  22. A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease. Eur Urol. 2018 01; 73(1):129-138.
    View in: PubMed
    Score: 0.029
  23. Cardiovascular disease risk and androgen deprivation therapy in patients with localised prostate cancer: a prospective cohort study. Br J Cancer. 2017 Oct 10; 117(8):1233-1240.
    View in: PubMed
    Score: 0.028
  24. Decision-making processes among men with low-risk prostate cancer: A survey study. Psychooncology. 2018 01; 27(1):325-332.
    View in: PubMed
    Score: 0.028
  25. Physicians' Perceptions of Factors Influencing the Treatment Decision-making Process for Men With Low-risk Prostate Cancer. Urology. 2017 09; 107:86-95.
    View in: PubMed
    Score: 0.028
  26. Physicians' perspectives on the informational needs of low-risk prostate cancer patients. Health Educ Res. 2017 04 01; 32(2):134-152.
    View in: PubMed
    Score: 0.028
  27. Mortality and Androgen Deprivation Therapy as Salvage Treatment for Biochemical Recurrence after Primary Therapy for Clinically Localized Prostate Cancer. J Urol. 2017 06; 197(6):1448-1454.
    View in: PubMed
    Score: 0.027
  28. Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study. Lancet Neurol. 2006 Nov; 5(11):917-23.
    View in: PubMed
    Score: 0.027
  29. 5-Alpha Reductase Inhibitors and the Risk of Prostate Cancer Mortality in Men Treated for Benign Prostatic Hyperplasia. Mayo Clin Proc. 2016 Dec; 91(12):1717-1726.
    View in: PubMed
    Score: 0.027
  30. Use of sildenafil or other phosphodiesterase inhibitors and risk of melanoma. Br J Cancer. 2016 09 27; 115(7):895-900.
    View in: PubMed
    Score: 0.026
  31. California Men's Health Study (CMHS): a multiethnic cohort in a managed care setting. BMC Public Health. 2006 Jun 30; 6:172.
    View in: PubMed
    Score: 0.026
  32. Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer. Cancer Epidemiol Biomarkers Prev. 2016 08; 25(8):1240-50.
    View in: PubMed
    Score: 0.026
  33. Use of androgen deprivation therapy as salvage treatment after primary therapy for clinically localized prostate cancer. World J Urol. 2016 Dec; 34(12):1611-1619.
    View in: PubMed
    Score: 0.026
  34. Sociodemographic and Clinical Predictors of Switching to Active Treatment among a Large, Ethnically Diverse Cohort of Men with Low Risk Prostate Cancer on Observational Management. J Urol. 2016 Sep; 196(3):734-40.
    View in: PubMed
    Score: 0.026
  35. Physical Activity and Risk of Male Breast Cancer. Cancer Epidemiol Biomarkers Prev. 2015 Dec; 24(12):1898-901.
    View in: PubMed
    Score: 0.025
  36. Risk of Cardiovascular Disease Associated with a Restless Legs Syndrome Diagnosis in a Retrospective Cohort Study from Kaiser Permanente Northern California. Sleep. 2015 Jul 01; 38(7):1009-15.
    View in: PubMed
    Score: 0.024
  37. Characterizing Race/Ethnicity and Genetic Ancestry for 100,000 Subjects in the Genetic Epidemiology Research on Adult Health and Aging (GERA) Cohort. Genetics. 2015 Aug; 200(4):1285-95.
    View in: PubMed
    Score: 0.024
  38. Automated Assay of Telomere Length Measurement and Informatics for 100,000 Subjects in the Genetic Epidemiology Research on Adult Health and Aging (GERA) Cohort. Genetics. 2015 Aug; 200(4):1061-72.
    View in: PubMed
    Score: 0.024
  39. Prediagnostic Sex Steroid Hormones in Relation to Male Breast Cancer Risk. J Clin Oncol. 2015 Jun 20; 33(18):2041-50.
    View in: PubMed
    Score: 0.024
  40. Reply: To PMID 25623697. Urology. 2015 Feb; 85(2):393.
    View in: PubMed
    Score: 0.024
  41. Imputation of the rare HOXB13 G84E mutation and cancer risk in a large population-based cohort. PLoS Genet. 2015 Jan; 11(1):e1004930.
    View in: PubMed
    Score: 0.024
  42. Risk of diabetes among patients receiving primary androgen deprivation therapy for clinically localized prostate cancer. J Urol. 2015 Jun; 193(6):1956-62.
    View in: PubMed
    Score: 0.024
  43. Association between cannabis use and the risk of bladder cancer: results from the California Men's Health Study. Urology. 2015 Feb; 85(2):388-92.
    View in: PubMed
    Score: 0.023
  44. Progression and treatment of incident lower urinary tract symptoms (LUTS) among men in the California Men's Health Study. BJU Int. 2015 Jan; 115(1):127-33.
    View in: PubMed
    Score: 0.023
  45. Prostate cancer incidence and prostate-specific antigen testing among HIV-positive and HIV-negative men. J Acquir Immune Defic Syndr. 2014 Aug 15; 66(5):495-502.
    View in: PubMed
    Score: 0.023
  46. The risk for malignant primary adult-onset glioma in a large, multiethnic, managed-care cohort: cigarette smoking and other lifestyle behaviors. J Neurooncol. 2004 May; 68(1):57-69.
    View in: PubMed
    Score: 0.023
  47. Effectiveness of primary androgen-deprivation therapy for clinically localized prostate cancer. J Clin Oncol. 2014 May 01; 32(13):1324-30.
    View in: PubMed
    Score: 0.022
  48. Cohort study of insulin glargine and risk of breast, prostate, and colorectal cancer among patients with diabetes. Diabetes Care. 2013 Dec; 36(12):3953-60.
    View in: PubMed
    Score: 0.022
  49. Family history of diabetes and pancreatic cancer as risk factors for pancreatic cancer: the PACIFIC study. Cancer Epidemiol Biomarkers Prev. 2013 Oct; 22(10):1913-7.
    View in: PubMed
    Score: 0.022
  50. Association of body mass index and prostate cancer mortality. Obes Res Clin Pract. 2014 Jul-Aug; 8(4):e374-81.
    View in: PubMed
    Score: 0.021
  51. Efficacy of intermittent androgen deprivation therapy vs conventional continuous androgen deprivation therapy for advanced prostate cancer: a meta-analysis. Urology. 2013 Aug; 82(2):327-33.
    View in: PubMed
    Score: 0.021
  52. Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial. Headache. 2003 Jun; 43(6):601-10.
    View in: PubMed
    Score: 0.021
  53. Immunohistochemical expression of ERG in the molecular epidemiology of fatal prostate cancer study. Prostate. 2013 Sep; 73(13):1371-7.
    View in: PubMed
    Score: 0.021
  54. Impact of type 2 diabetes on lower urinary tract symptoms in men: a cohort study. BMC Urol. 2013 Feb 20; 13:12.
    View in: PubMed
    Score: 0.021
  55. A prognostic assay to identify patients at high risk of mortality despite small, node-negative lung tumors. JAMA. 2012 Oct 24; 308(16):1629-31.
    View in: PubMed
    Score: 0.020
  56. Clinical effectiveness of pneumococcal polysaccharide vaccine in men: California Men's Health Study. Vaccine. 2012 Aug 17; 30(38):5625-30.
    View in: PubMed
    Score: 0.020
  57. Complementary and alternative medicine use, patient-reported outcomes, and treatment satisfaction among men with localized prostate cancer. Urology. 2012 May; 79(5):1034-41.
    View in: PubMed
    Score: 0.020
  58. A high-density genome-wide association screen of sporadic ALS in US veterans. PLoS One. 2012; 7(3):e32768.
    View in: PubMed
    Score: 0.020
  59. A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies. Lancet. 2012 Mar 03; 379(9818):823-32.
    View in: PubMed
    Score: 0.019
  60. Valvular heart disease in patients exposed to pergolide: insights from the clinical presentation. Pharmacoepidemiol Drug Saf. 2012 Mar; 21(3):276-80.
    View in: PubMed
    Score: 0.019
  61. Preventive care and health behaviors among overweight/obese men in HMOs. Am J Manag Care. 2012 Jan; 18(1):25-32.
    View in: PubMed
    Score: 0.019
  62. A comparison of lifestyle and behavioral cardiovascular disease risk factors between Asian Indian and White non-Hispanic men. Ethn Dis. 2012; 22(2):168-74.
    View in: PubMed
    Score: 0.019
  63. Evaluating racial/ethnic disparities in lower urinary tract symptoms in men. J Urol. 2012 Jan; 187(1):185-9.
    View in: PubMed
    Score: 0.019
  64. Population-based study of erectile dysfunction and polypharmacy. BJU Int. 2012 Jul; 110(2):254-9.
    View in: PubMed
    Score: 0.019
  65. Contribution of common medications to lower urinary tract symptoms in men. Arch Intern Med. 2011 Oct 10; 171(18):1680-2.
    View in: PubMed
    Score: 0.019
  66. Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium. J Neurol Sci. 2011 Aug 15; 307(1-2):22-9.
    View in: PubMed
    Score: 0.018
  67. Regular nonsteroidal anti-inflammatory drug use and erectile dysfunction. J Urol. 2011 Apr; 185(4):1388-93.
    View in: PubMed
    Score: 0.018
  68. Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohorts. Nat Commun. 2021 02 12; 12(1):970.
    View in: PubMed
    Score: 0.018
  69. Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's disease. Eur J Neurol. 2011 May; 18(5):756-65.
    View in: PubMed
    Score: 0.018
  70. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. Nat Genet. 2021 01; 53(1):65-75.
    View in: PubMed
    Score: 0.018
  71. Complementary and alternative medicine use among newly diagnosed prostate cancer patients. Support Care Cancer. 2012 Jan; 20(1):65-73.
    View in: PubMed
    Score: 0.018
  72. Familial aggregation of Parkinson's disease in a multiethnic community-based case-control study. Mov Disord. 2010 Nov 15; 25(15):2587-94.
    View in: PubMed
    Score: 0.018
  73. Comorbid cancer in Parkinson's disease. Mov Disord. 2010 Sep 15; 25(12):1809-17.
    View in: PubMed
    Score: 0.018
  74. Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts. Nat Commun. 2020 09 04; 11(1):4423.
    View in: PubMed
    Score: 0.018
  75. Patient recruitment methods to evaluate treatment decision making for localized prostate cancer. Am J Clin Oncol. 2010 Aug; 33(4):381-6.
    View in: PubMed
    Score: 0.017
  76. Unanticipated and underappreciated outcomes during management of local stage prostate cancer: a prospective survey. J Urol. 2010 Jul; 184(1):120-5.
    View in: PubMed
    Score: 0.017
  77. Autoimmune diseases prior to the diagnosis of multiple sclerosis: a population-based case-control study. Mult Scler. 2010 Jul; 16(7):855-61.
    View in: PubMed
    Score: 0.017
  78. Pneumococcal vaccination and risk of acute myocardial infarction and stroke in men. JAMA. 2010 May 05; 303(17):1699-706.
    View in: PubMed
    Score: 0.017
  79. Reliability and validity of two self-administered questionnaires for screening restless legs syndrome in population-based studies. Sleep Med. 2010 Feb; 11(2):154-60.
    View in: PubMed
    Score: 0.017
  80. Prostatitis, sexually transmitted diseases, and prostate cancer: the California Men's Health Study. PLoS One. 2010 Jan 15; 5(1):e8736.
    View in: PubMed
    Score: 0.017
  81. Red wine consumption and risk of prostate cancer: the California men's health study. Int J Cancer. 2010 Jan 01; 126(1):171-9.
    View in: PubMed
    Score: 0.017
  82. Correlates of prostate-specific antigen testing in a large multiethnic cohort. Am J Manag Care. 2009 Nov; 15(11):793-9.
    View in: PubMed
    Score: 0.017
  83. Clinical features in early Parkinson disease and survival. Arch Neurol. 2009 Nov; 66(11):1353-8.
    View in: PubMed
    Score: 0.017
  84. Generational status and duration of residence predict diabetes prevalence among Latinos: the California Men's Health Study. BMC Public Health. 2009 Oct 19; 9:392.
    View in: PubMed
    Score: 0.016
  85. Racial disparities in erectile dysfunction among participants in the California Men's Health Study. J Sex Med. 2009 Dec; 6(12):3433-9.
    View in: PubMed
    Score: 0.016
  86. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet. 2009 Sep; 41(9):986-90.
    View in: PubMed
    Score: 0.016
  87. Statin use and risk of colorectal cancer in a cohort of middle-aged men in the US: a prospective cohort study. Drugs. 2009 Jul 30; 69(11):1445-57.
    View in: PubMed
    Score: 0.016
  88. Access to information sources and treatment considerations among men with local stage prostate cancer. Urology. 2009 Sep; 74(3):509-15.
    View in: PubMed
    Score: 0.016
  89. Effect of intensive glycemic control and diabetes complications on lower urinary tract symptoms in men with type 1 diabetes: Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Diabetes Care. 2009 Apr; 32(4):664-70.
    View in: PubMed
    Score: 0.016
  90. Glycemic status and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2008 Mar; 17(3):628-35.
    View in: PubMed
    Score: 0.015
  91. Statin use and risk of prostate cancer in the California Men's Health Study cohort. Cancer Epidemiol Biomarkers Prev. 2007 Nov; 16(11):2218-25.
    View in: PubMed
    Score: 0.014
  92. Minimum incidence of primary cervical dystonia in a multiethnic health care population. Neurology. 2007 Aug 14; 69(7):676-80.
    View in: PubMed
    Score: 0.014
  93. Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry. J Natl Cancer Inst. 2017 08 01; 109(8).
    View in: PubMed
    Score: 0.014
  94. Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol. 2007 Jul; 64(7):990-7.
    View in: PubMed
    Score: 0.014
  95. Effect of non-steroidal anti-inflammatory medications on the risk of amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2007 Jun; 8(3):157-63.
    View in: PubMed
    Score: 0.014
  96. Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer. Nat Commun. 2017 01 31; 8:14248.
    View in: PubMed
    Score: 0.014
  97. Obesity, diabetes, serum glucose, and risk of primary liver cancer by birth cohort, race/ethnicity, and sex: Multiphasic health checkup study. Cancer Epidemiol. 2016 06; 42:140-6.
    View in: PubMed
    Score: 0.013
  98. Air Pollution and Pulmonary Tuberculosis: A Nested Case-Control Study among Members of a Northern California Health Plan. Environ Health Perspect. 2016 06; 124(6):761-8.
    View in: PubMed
    Score: 0.013
  99. Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes. JAMA. 2015 Jul 21; 314(3):265-77.
    View in: PubMed
    Score: 0.012
  100. Genotyping Informatics and Quality Control for 100,000 Subjects in the Genetic Epidemiology Research on Adult Health and Aging (GERA) Cohort. Genetics. 2015 Aug; 200(4):1051-60.
    View in: PubMed
    Score: 0.012
  101. A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences. Cancer Discov. 2015 Aug; 5(8):878-91.
    View in: PubMed
    Score: 0.012
  102. Cigarette smoking and pulmonary tuberculosis in northern California. J Epidemiol Community Health. 2015 Jun; 69(6):568-73.
    View in: PubMed
    Score: 0.012
  103. Urologic complications of diabetes. Diabetes Care. 2005 Jan; 28(1):177-85.
    View in: PubMed
    Score: 0.012
  104. Tobacco and alcohol in relation to male breast cancer: an analysis of the male breast cancer pooling project consortium. Cancer Epidemiol Biomarkers Prev. 2015 Mar; 24(3):520-31.
    View in: PubMed
    Score: 0.012
  105. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. Hum Mol Genet. 2014 Dec 15; 23(24):6616-33.
    View in: PubMed
    Score: 0.011
  106. Testing for prostate and colorectal cancer: comparison of self-report and medical record audit. Prev Med. 2004 Jul; 39(1):27-35.
    View in: PubMed
    Score: 0.011
  107. Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results. J Natl Cancer Inst. 2014 Mar; 106(3):djt465.
    View in: PubMed
    Score: 0.011
  108. An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population. PLoS One. 2013; 8(9):e72311.
    View in: PubMed
    Score: 0.011
  109. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol. 2003 Jun 01; 157(11):1015-22.
    View in: PubMed
    Score: 0.011
  110. Initial treatment for prostate carcinoma in relation to comorbidity and symptoms. Cancer. 2002 Dec 01; 95(11):2308-15.
    View in: PubMed
    Score: 0.010
  111. Air pollution and hospital admissions for ischemic heart disease in persons with congestive heart failure or arrhythmia. Environ Health Perspect. 2002 Dec; 110(12):1247-52.
    View in: PubMed
    Score: 0.010
  112. Different slopes for different folks: socioeconomic and racial/ethnic disparities in asthma and hay fever among 173,859 U.S. men and women. Environ Health Perspect. 2002 Apr; 110 Suppl 2:211-6.
    View in: PubMed
    Score: 0.010
  113. Effect of sexually transmitted infections, lifetime sexual partner count, and recreational drug use on lower urinary tract symptoms in men who have sex with men. Urology. 2012 Jan; 79(1):188-93.
    View in: PubMed
    Score: 0.009
  114. Cohort study of pioglitazone and cancer incidence in patients with diabetes. Diabetes Care. 2011 Apr; 34(4):923-9.
    View in: PubMed
    Score: 0.009
  115. HIV status is an independent risk factor for reporting lower urinary tract symptoms. J Urol. 2011 May; 185(5):1710-5.
    View in: PubMed
    Score: 0.009
  116. Body size, age at shaving initiation, and prostate cancer in a large, multiracial cohort. Prostate. 2000 May 01; 43(2):136-43.
    View in: PubMed
    Score: 0.009
  117. Increased risk of high-grade prostate cancer among infertile men. Cancer. 2010 May 01; 116(9):2140-7.
    View in: PubMed
    Score: 0.009
  118. The cost of health conditions in a health maintenance organization. Med Care Res Rev. 2000 Mar; 57(1):92-109.
    View in: PubMed
    Score: 0.008
  119. Medical history, body size, and cigarette smoking in relation to fatal prostate cancer. Cancer Causes Control. 2010 Jan; 21(1):117-25.
    View in: PubMed
    Score: 0.008
  120. Digital rectal examination and mortality from prostate cancer. Urology. 1999 Apr; 53(4):863-4.
    View in: PubMed
    Score: 0.008
  121. Cause of death in men diagnosed with prostate carcinoma. Cancer. 1998 Sep 15; 83(6):1180-8.
    View in: PubMed
    Score: 0.008
  122. Risk factors for incident and recurrent condylomata acuminata among men. A population-based study. Sex Transm Dis. 1998 Jul; 25(6):278-84.
    View in: PubMed
    Score: 0.008
  123. Race, prostate cancer survival, and membership in a large health maintenance organization. J Natl Cancer Inst. 1998 Jul 01; 90(13):986-90.
    View in: PubMed
    Score: 0.008
  124. Racial differences in treatment of early-stage prostate cancer. Urology. 2008 Jun; 71(6):1172-6.
    View in: PubMed
    Score: 0.007
  125. Medically recognized urinary incontinence and risks of hospitalization, nursing home admission and mortality. Age Ageing. 1997 Sep; 26(5):367-74.
    View in: PubMed
    Score: 0.007
  126. Correlates of screening sigmoidoscopy use among men in a large nonprofit health plan. Cancer. 2007 Jul 15; 110(2):275-81.
    View in: PubMed
    Score: 0.007
  127. Take-home lead poisoning in a child from his father's occupational exposure. Am J Ind Med. 1996 May; 29(5):507-8.
    View in: PubMed
    Score: 0.006
  128. Screening by prostate-specific antigen and digital rectal examination in relation to prostate cancer mortality: a case-control study. Epidemiology. 2005 May; 16(3):367-76.
    View in: PubMed
    Score: 0.006
  129. Aspartame ingestion and headaches: a randomized crossover trial. Neurology. 1994 Oct; 44(10):1787-93.
    View in: PubMed
    Score: 0.006
  130. Diet and genital warts: a case-control study. Sex Transm Dis. 1994 May-Jun; 21(3):149-54.
    View in: PubMed
    Score: 0.006
  131. Exposure to engine exhaust and risk of subsequent cancer. J Occup Med. 1993 Mar; 35(3):307-11.
    View in: PubMed
    Score: 0.005
  132. Risk factors for pancreatic cancer: an exploratory study. Int J Epidemiol. 1993 Feb; 22(1):30-7.
    View in: PubMed
    Score: 0.005
  133. Forced expiratory volume (1 second) and lung cancer incidence and mortality. Epidemiology. 1992 May; 3(3):253-7.
    View in: PubMed
    Score: 0.005
  134. Occupation and the occurrence of testicular cancer. Am J Ind Med. 1991; 19(3):327-37.
    View in: PubMed
    Score: 0.004
  135. Is testicular cancer incidence in blacks increasing? Am J Public Health. 1989 Nov; 79(11):1553-4.
    View in: PubMed
    Score: 0.004

© 2024 Kaiser Permanente